Tag

Chlorthalidone

All articles tagged with #chlorthalidone

health14 days ago•1 min saved

Inventia Healthcare Recalls 13,500 Chlorthalidone Bottles Over Dissolution Failures

Inventia Healthcare Limited has voluntarily recalled 13,567 bottles of chlorthalidone 25 mg tablets after the medication failed dissolution testing. This is the second recall for this specific drug by the India-based manufacturer in 2026, following an earlier action in June. The FDA has classified the recall as Class II, indicating that while the risk of serious harm is remote, the product may cause temporary or medically reversible adverse health consequences. Patients are advised to consult their healthcare providers before stopping the medication, as abrupt discontinuation could lead to dangerous spikes in blood pressure.

via New York Post|

#chlorthalidone #fda #health

health15 days ago•12 min saved

FDA classifies Inventia’s chlorthalidone recall as Class II after dissolution failures

The FDA has classified a nationwide recall of over 25,000 bottles of chlorthalidone 25 mg tablets as Class II, citing failures in dissolution specifications that may impair drug absorption. Manufactured by India-based Inventia Healthcare Limited, the affected batches were distributed across the United States. Patients are advised to consult their healthcare providers before discontinuing the medication, as stopping treatment may pose greater risks than continuing use of the recalled product.

via USA Today|

#blood-pressure #chlorthalidone #drug-recall

health15 days ago•58 min saved

FDA Upgrades Chlorthalidone Recall to Class II After Dissolution Failures

The FDA has escalated a nationwide recall of 13,567 bottles of chlorthalidone 25mg tablets to Class II status due to failures in dissolution specifications. Manufactured by Inventia Healthcare Limited, the affected medication was distributed across the US and is identified by NDC number 64980-599-01. This is the second recall for this specific drug in three months, following a similar issue with Rising Pharma Holdings in June. Patients are advised to stop using the affected product and consult their healthcare provider for an alternative.

via Yahoo|

#blood-pressure #chlorthalidone #drug-recall

health16 days ago•78 min saved

FDA Recalls 13,500 Chlorthalidone Bottles Over Dissolution Failures

The FDA has issued a Class II recall for 13,567 bottles of chlorthalidone 25mg tablets manufactured by Inventia Healthcare Limited. The recall, initially issued on September 3 and upgraded on September 17, stems from the medication failing dissolution specifications, which may prevent the drug from releasing its active ingredient properly. This is the second recall for this specific medication in three months, following a similar issue with Rising Pharma Holdings in June. Chlorthalidone is a diuretic used to treat high blood pressure and fluid retention. Patients are advised to stop using the affected product and consult their healthcare provider for an alternative.

via AOL.com|

#chlorthalidone #class-ii-recall #dissolution-specifications

health16 days ago•37 min saved

FDA Classifies Second Chlorthalidone Recall as Class II Due to Dissolution Failures

The FDA has classified a second nationwide recall of chlorthalidone tablets as Class II, affecting over 13,000 bottles. Manufactured by Inventia Healthcare, the medication failed dissolution tests, potentially reducing its effectiveness for treating high blood pressure. Patients are advised to contact their healthcare providers before stopping the medication.

via Yahoo News Singapore|

#chlorthalidone #drug-recall #fda

health19 days ago•77 min saved

FDA Issues Class II Recall for 13,567 Bottles of Chlorthalidone Due to Dissolution Failures

The FDA has announced a Class II recall of 13,567 bottles of chlorthalidone 25mg tablets nationwide after the medication failed dissolution tests. This is the second recall for this specific drug and manufacturer in three months, affecting patients who rely on the medication for hypertension and fluid retention.

via AOL.com|

#chlorthalidone #drug-recall #fda

health20 days ago

Second Chlorthalidone Recall in Three Months Affects 13,567 Bottles Nationwide

The FDA has classified a recall of 13,567 bottles of chlorthalidone 25mg tablets as Class II after they failed dissolution tests. This is the second recall for this specific medication and manufacturer in three months, affecting patients nationwide who rely on the drug for hypertension and fluid retention.

via WSB-TV|

#blood-pressure #chlorthalidone #dissolution-failure

health3 months ago•391 min saved

Thousands of Chlorthalidone BP Pills Recalled Over Dissolution Failures

The FDA is recalling about 11,400 bottles of the 25 mg diuretic chlorthalidone after testing showed some lots failed dissolution specifications, potentially reducing effectiveness. The tablets were made by Inventia Healthcare Limited (Mumbai) and distributed nationwide by Rising Pharma Holdings; affected products include 100-count (NDC 64980-599-01, batch RISA24001, exp. 04/2027) and 1,000-count (NDC 64980-599-10, batch RISB24002, exp. 04/2027) bottles. The recall is Class II (moderate hazard), and the FDA has not issued patient-specific instructions yet; patients should check their labels and consult a doctor or pharmacist if they have recalled tablets.

via TODAY.com|

#blood-pressure #chlorthalidone #dissolution

health3 months ago•26 min saved

Widespread recall of chlorthalidone BP tablets over dissolution issue

More than 11,000 bottles of the blood pressure medication Chlorthalidone Tablets USP, 25 mg, were recalled nationwide after a manufacturing issue caused dissolution failures. The recall involves both 100-count and 1,000-count bottles distributed in the United States by Rising Pharma Holdings Inc. of New Jersey; 11,460 bottles are included. Inventia Healthcare Limited initiated the voluntary recall on June 5. The FDA enforcement report notes the tablets may not dissolve as intended, and patients should consult their pharmacist or healthcare provider if they may have a recalled bottle; do not stop taking prescribed medication without medical advice.

via WKRC|

#chlorthalidone #dissolution #fda

nation-and-world3 months ago•24 min saved

Nationwide recall issued for common hypertension drug due to dissolution defect

More than 11,000 bottles of chlorthalidone tablets (25 mg) used to treat high blood pressure have been recalled nationwide after a manufacturing issue caused dissolution specifications to fail. Inventia Healthcare Limited initiated the voluntary recall on June 5, with 100-count bottles (Lot RISA24001) and 1,000-count bottles (Lot RISB24002) distributed in the U.S. by Rising Pharma Holdings Inc. The FDA has not yet assigned a recall classification, and no public press release had been issued; patients should contact their pharmacist or healthcare provider if they believe they have a recalled bottle and should not stop taking prescribed medication without medical advice.

via KOMO|

#blood-pressure #chlorthalidone #dissolution-failure